These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8201781)

  • 21. Comparative trial of atenolol and propranolol in hyperthyroidism.
    McDevitt DG; Nelson JK
    Br J Clin Pharmacol; 1978 Sep; 6(3):233-7. PubMed ID: 356867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthyroidism is associated with lengthening of ventricular repolarization.
    Colzani RM; Emdin M; Conforti F; Passino C; Scarlattini M; Iervasi G
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):27-32. PubMed ID: 11453949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration.
    Feely J; Crooks J; Stevenson IH
    Br J Clin Pharmacol; 1981 Jul; 12(1):73-8. PubMed ID: 6264937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of propranolol and verapamil on hyperthyroid heart symptoms and function, assessed by systolic time intervals.
    Nordin H; Galløe AM; Ladefoged SD; Badskjaer J
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):297-300. PubMed ID: 8498148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias.
    Phillips EM; Turner P; Houghton J; Ferriman DG
    Postgrad Med J; 1973 Jan; 49(567):18-23. PubMed ID: 4147246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the block of beta-adrenergic receptors in tachycardia due to thyreotoxicosis].
    De Petra V; Rossi A; Maino R
    Cardiol Prat; 1969 Dec; 20(6):487-90. PubMed ID: 4395245
    [No Abstract]   [Full Text] [Related]  

  • 27. No enhanced elimination of propranolol in patients with hyperthyroidism.
    Ishizaki T; Masuno M; Tawara K
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of propranolol in hypertensive patients after sublingual administration: systemic availability.
    Mansur AP; Avakian SD; Paula RS; Donzella H; Santos SR; Ramires JA
    Braz J Med Biol Res; 1998 May; 31(5):691-6. PubMed ID: 9698776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol dynamics in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Clin Pharmacol Ther; 1980 Jul; 28(1):40-4. PubMed ID: 7389252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.
    Fujimura A; Kumagai Y; Sugimoto K; Nakashima H; Kajiyama H; Ebihara A; Ohashi K
    Eur J Clin Pharmacol; 1990; 38(2):133-7. PubMed ID: 2338109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma propranolol steady state concentrations in thyroid disorders.
    Feely J; Crooks J; Stevenson IH
    Eur J Clin Pharmacol; 1981; 19(5):329-33. PubMed ID: 7238561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal transit in hyperthyroid patients before and after propranolol treatment.
    Bozzani A; Camboni MG; Tidone L; Cesari P; Della Mussia F; Quatrini M; Ghilardi G; Ferrar L; Bianchi PA
    Am J Gastroenterol; 1985 Jul; 80(7):550-2. PubMed ID: 4014104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol dosage in thyrotoxicosis.
    Feely J; Forrest A; Gunn A; Hamilton W; Stevenson I; Crooks J
    J Clin Endocrinol Metab; 1980 Sep; 51(3):658-61. PubMed ID: 7410541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.
    Nilsson OR; Melander A; Tegler L
    Eur J Clin Pharmacol; 1980 Oct; 18(4):315-20. PubMed ID: 7439251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of bilateral ovarectomy on sympathetic cardiovascular reflexes and the treatment of the postoperative vegetative syndrome with propranolol and oxazepam.
    Erkkola R; Iisalo E; Punnonen R
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:31. PubMed ID: 5287102
    [No Abstract]   [Full Text] [Related]  

  • 37. Autonomic contribution to the blood pressure and heart rate variability changes in early experimental hyperthyroidism.
    Safa-Tisseront V; Ponchon P; Laude D; Elghozi JL
    J Hypertens; 1998 Dec; 16(12 Pt 2):1989-92. PubMed ID: 9886887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous 24-hour electrocardiography in thyrotoxicosis before and after treatment.
    Northcote RJ; MacFarlane P; Kesson CM; Ballantyne D
    Am Heart J; 1986 Aug; 112(2):339-44. PubMed ID: 2426935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the thyroid in the control of heart-rate.
    McDevitt DG; Shanks RG; Hadden DR; Montgomery DA; Weaver JA
    Lancet; 1968 May; 1(7550):998-1000. PubMed ID: 4171838
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.
    McCourty JC; Silas JH; Tucker GT; Lennard MS
    Br J Clin Pharmacol; 1988 Mar; 25(3):349-57. PubMed ID: 3358897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.